Ilesol Pharmaceuticals is proud to announce that EIHA’s CBD isolate dossier, RP427, has finally been validated by the UK’s Food…
CBD is safe and tolerable for short-term use for a maximum of 30 days at a maximum dose of 200…
As was the case in other countries, over-the-counter CBD products in the UK have proved to be substandard. A recent…
Cannabis will be far bigger for the UK economy than Scotch Whiskey, said Nicholas Morland, CEO of Tenacious Labs, Secretariat…
Almost 2,500 new CBD products have been added to the Food Standards Agency’s (FSA) public list this week. The CBD…
Ahead of Cannabis Europa London 2022, BusinessCann spoke to the organization’s managing director Lorenza Romanese about the current state of…
Today, the Food Standards Agency (FSA) published a list of CBD products that have credible applications for authorization with the…
Following a positive opinion of the Standing Committee for Foodstuffs, the Commission amended Regulation (EC) No 1881/2006 as regards the…
On the 2nd of December, the 1st anniversary of the historic UN cannabis vote, 181 NGOs from 56 countries called upon…
Lack of progress with the applications and launch of the INCB’s Cannabis Initiative has caused growing concerns in the European…
Last week, from June 16-18, the European Industrial Hemp Association (EIHA) hosted its 18th EIHA Conference. The three-day online event,…
British Government should move the licensing regime for cannabinoid pharmaceutical research and CBD over-the-counter medicines from the Home Office to…
